Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration of ...
-- PCRX-201 demonstrated sustained clinical efficacy with improvements in pain, stiffness, and function for up to three years – BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, ...
Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.
BETTENDORF, Iowa — A UnityPoint Health - Trinity doctor is using an innovative procedure to improve recovery after a knee replacement surgery. Dr. Maruti Kari in the hospital's pain management clinic ...
(RTTNews) - Pacira BioSciences (PCRX) has entered a strategic collaboration with Johnson & Johnson MedTech to co-promote ZILRETTA®, its extended-release intra-articular injection for osteoarthritis ...
Hosted on MSN
The Medicine Cabinet: Ask the Harvard Experts: When to consider injections for knee osteoarthritis
Q: I have osteoarthritis in both knees. The left knee is especially painful and stiff. When should a person consider getting knee injections? A: People can often manage the pain and improve mobility ...
Hosted on MSN
People are getting costly stem cell injections for knee osteoarthritis, but we don't know if they work
More than 500 million people around the world live with osteoarthritis. The knee is affected more often than any other joint, with symptoms (such as pain, stiffness and reduced movement) affecting ...
On Tuesday, Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch nerves to manage chronic low back pain. The ioveraº system is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback